Common use of Odškodnění Clause in Contracts

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim from a Subject of illness or injury that is claimed to be due to an adverse reaction to the Study Drug administered pursuant to the Protocol or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim from a Study Subject of illness or injury health damage that is claimed to be due to an adverse reaction to the Study Drug administered pursuant to the Protocol or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Study Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Sponsor Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR Sponsor to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR Sponsor in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to solely handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim12.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim12.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Failure to so notify CRO shall relieve SPONSOR of any obligation to indemnify Institution. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.

Odškodnění. Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and all concerned – the CRO, the Institution and the Investigator shall cooperate fully with SPONSOR in its handling of the claimclaim by providing the necessary assistance and documents.

Odškodnění. Institution 1Institution and Investigator shall immediately notify CRO in writing of any claim of illness or injury that is claimed to be due to an adverse reaction to the Study Drug or any of the clinical intervention or procedures that are provided for or required by the Protocol to which the Subjects would not have been exposed but for their participation in the Study. Institution and Investigator shall allow SPONSOR to handle such claim (including, if applicable, settlement negotiations), and shall cooperate fully with SPONSOR in its handling of the claim.